Alexander B, Perry P J
Division of Clinical Pharmacy, College of Pharmacy, University of Iowa, Iowa City 52242.
J Subst Abuse Treat. 1991;8(1-2):9-17. doi: 10.1016/0740-5472(91)90022-3.
Management of benzodiazepine (BZD) tolerance is divided into low- and high-dose withdrawal. Low-dose withdrawal includes patients who have received manufacturer-recommended doses of BZD on a daily basis for longer than 1 month. Gradual tapering of the BZD over 4 weeks on an outpatient basis is suggested. High-dose withdrawal includes patients who have been ingesting doses of BZD greater than the equivalent of diazepam 40 mg/d for longer than 8 months. It is recommended that the patients be tolerance tested with diazepam and, if tolerant, tapered off medication as inpatients at a rate of 10% per day. Triazolobenzodiazepines may be exceptions to these recommendations. Alprazolam should be titrated at a rate of 0.5 mg three times a day regardless of whether the patient is being tapered for low- or high-dose withdrawal.
苯二氮䓬类药物(BZD)耐受性的管理分为低剂量和高剂量撤药。低剂量撤药适用于那些每日接受制造商推荐剂量的BZD超过1个月的患者。建议在门诊基础上,在4周内逐渐减少BZD剂量。高剂量撤药适用于那些摄入的BZD剂量超过地西泮等效剂量40mg/d且持续超过8个月的患者。建议对这些患者用地西泮进行耐受性测试,如果耐受,则作为住院患者以每天10%的速率逐渐减少药物剂量。三唑苯二氮䓬类药物可能是这些建议的例外情况。无论患者是因低剂量还是高剂量撤药而逐渐减量,阿普唑仑均应以每天三次、每次0.5mg的速率进行滴定。